Potassium Chloride Tablet, Film Coated, Extended Release
Product Images NDC 70436-002

6 FDA label images from Slate Run Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 70436-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600mg-100ct-slaterun (600mg 100ct Slaterun)

600mg-100ct-slaterun (600mg 100ct Slaterun)
Potassium Chloride Extended-Release Tablets USP 600 mg (8 mEq) film-coated tablets, extended release, oral dosage form. The label shows a 100 tablet count bottle distributed by Slate Run Pharmaceuticals, LLC. Storage instructions specify 20° to 25°C with permitted excursions. Includes patient information about the tablet's unabsorbed matrix and child-resistant closure requirements. Manufactured by Yichang Humanwell Oral Solid Dosage Plant in China.*
FDA Label Image

600mg-500ct-slaterun (600mg 500ct Slaterun)

600mg-500ct-slaterun (600mg 500ct Slaterun)
Label for Potassium Chloride Extended-Release Tablets USP, 600 mg strength (8 mEq) oral tablets. The label indicates a supply of 500 tablets. It includes storage instructions, patient information, and manufacturer details (Yichang Humanwell Oral Solid Dosage Plant, China) with distribution by Slate Run Pharmaceuticals, LLC, Columbus, Ohio. The label states the product is prescription only (Rx only).*
FDA Label Image

600mg-1000ct-slaterun (600mg 1000ct Slaterun)

600mg-1000ct-slaterun (600mg 1000ct Slaterun)
Potassium Chloride Extended-Release Tablets USP, 8 mEq (600 mg), film-coated, oral dosage form. The label shows a package of 1000 tablets manufactured by Yichang Humanwell Oral Solid Dosage Plant and distributed by Slate Run Pharmaceuticals, LLC. Storage instructions and patient information note are included on the label.*
FDA Label Image

750mg-100ct-slaterun (750mg 100ct Slaterun)

750mg-100ct-slaterun (750mg 100ct Slaterun)
Potassium Chloride Extended-Release Tablets USP 750 mg film-coated, extended-release tablets. The label indicates the dosage as 10 mEq (750 mg) and states the product is for oral use. It is manufactured by Yichang Humanwell and distributed by Slate Run Pharmaceuticals, LLC. The package contains 100 tablets. Storage and patient information details are provided on the label.*
FDA Label Image

750mg-500ct-slaterun (750mg 500ct Slaterun)

750mg-500ct-slaterun (750mg 500ct Slaterun)
Potassium Chloride Extended-Release Tablets USP, 750 mg (10 mEq) film-coated oral tablets in a 500-count package from Slate Run Pharmaceuticals, LLC. The label displays storage conditions, manufacturer and distributor information, and patient guidance about the extended-release matrix and safety precautions.*
FDA Label Image

750mg-1000ct-slaterun (750mg 1000ct Slaterun)

750mg-1000ct-slaterun (750mg 1000ct Slaterun)
Potassium Chloride Extended-Release Tablets USP 750 mg (10 mEq) label from Slate Run Pharmaceuticals, LLC. The label includes dosage form as extended-release tablets, storage instructions, patient information about matrix excretion, and manufacturer details including Yichang Humanwell Oral Solid Dosage Plant in China. Package size is 1000 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.